Asish K Ghosh

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Squamous Cell Carcinoma

Induced Apoptosis

Chronic Lymphocytic Leukemia

Top Venues

British journal of cancer

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Sutapa Sinha, Ray Guo, Miles D Del Busso, Weiguo Han, Justin Boysen, Linda E Wellik, Asish K Ghosh, Neil E Kay
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. British journal of cancer (2024)
Sutapa Sinha, Ray Guo, Miles D Del Busso, Weiguo Han, Justin Boysen, Linda E Wellik, Asish K Ghosh, Neil E Kay
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. British journal of cancer 131 (3) (2024)
Sutapa Sinha, Ray Guo, Miles D Del Busso, Weiguo Han, Justin Boysen, Linda E Wellik, Asish K Ghosh, Neil E Kay
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. British journal of cancer 131 (3) (2024)
Sutapa Sinha, Ray Guo, Miles D Del Busso, Weiguo Han, Justin Boysen, Linda E Wellik, Asish K Ghosh, Neil E Kay
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. British journal of cancer 131 (3) (2024)
Murali K Mamidi, Hasan Mahmud, Guru P Maiti, Mariana T Mendez, Stacey M Fernandes, Sara K Vesely, Jennifer Holter-Chakrabarty, Jennifer R Brown, Asish K Ghosh
Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cells. Leukemia 36 (7) (2022)
Guru P Maiti, Sutapa Sinha, Hasan Mahmud, Justin Boysen, Mariana T Mendez, Sara K Vesely, Jennifer Holter-Chakrabarty, Neil E Kay, Asish K Ghosh
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood cancer journal 11 (5) (2021)